查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014903

醫療設備外包市場：依服務類型、器材類型、外包模式和最終用戶分類－2026-2032年全球市場預測

Medical Device Outsourcing Market by Service Type, Device Type, Outsourcing Model, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年醫療設備外包市場價值為1,465億美元，預計到2026年將成長至1,576億美元，複合年成長率為9.23%，到2032年將達到2,718.2億美元。

主要市場統計數據
基準年 2025 1465億美元
預計年份：2026年 1576億美元
預測年份：2032年 2718.2億美元
複合年成長率 (%) 9.23%

本文重點概述了不斷變化的臨床、監管和供應趨勢如何重塑整個醫療設備生命週期的外包策略。

現代醫療設備產業正經歷劇烈的調整，其驅動力包括不斷變化的監管環境、技術的融合以及供應商經濟狀況的改變。參與醫療設備創新生命週期的相關人員正在重新評估哪些職能應該保留在內部，哪些職能應該外包，並尋求能夠支持成本效益、監管專業知識、品質保證和創新實施的合作夥伴。對於那些面臨產品開發週期縮短、複合產品日益複雜以及供應鏈健康狀況監控日益嚴格的企業而言，這種轉變是合理的。

從前瞻性的角度看待技術、監管和商業變革的融合，這些變革正在重新定義外包夥伴關係和預期。

變革性的變化正在重塑醫療設備製造商獲取關鍵服務的管道和方式，而這種變化是由技術、監管和市場進入等多方面因素共同驅動的。數位化和數據分析實現了遠端監控、預測性品管和虛擬化臨床操作，從而影響了合作夥伴的選擇標準和合約績效指標。同時，監管機構對可追溯性、互聯設備的網路安全以及上市後資料的要求也日益提高，促使製造商優先選擇具有監管前瞻性和完善合規框架的外包合作夥伴。

對不斷變化的關稅壓力如何推動供應商的地理重組以及重塑總成本和合規策略進行全面分析。

美國關稅環境的調整進一步增加了籌資策略的複雜性，迫使企業重新評估供應商地域分佈模型、關稅分類的影響以及相關成本。貿易政策的調整使得企業有必要重新評估跨境採購的總成本計算方式，特別是對於在最終組裝前需經過多個司法管轄區的零件和組裝。企業正在透過提高供應鏈透明度、與策略供應商重新談判合約條款以及評估近岸外包方案來應對這種情況，從而降低關稅波動風險。

將服務類別、設備複雜性、最終用戶行為和外包模式與夥伴關係設計和風險分配聯繫起來的詳細細分見解。

細分市場分析揭示了不同服務類型、設備類別、最終用戶和外包模式的需求促進因素各不相同，因此需要相應的合作夥伴能力和合約結構。按服務類型分類，市場涵蓋臨床試驗、設計與開發、物流、製造、包裝、法規事務、維修與維護、滅菌​​以及測試與檢驗。製造服務又細分為契約製造、客製化製造和OEM（原始設備製造商）。每個服務細分市場在品質、可追溯性和法規文件方面都有獨特的要求，這些要求會影響合作夥伴的評估標準和管治模式。

針對外包的區域差異化策略考量，平衡監管管道、成本結構、創新和市場接近性。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的籌資策略、監管時間表和成本結構均有顯著影響，每個地區在業務外包方面都展現出獨特的優勢和限制因素。在美洲，接近性大規模醫療保健市場以及成熟的法規結構為近岸製造和快速的臨床合作提供了支持，而不斷上漲的人事費用成本和合規成本則促使一些公司轉向自動化和產能最佳化。

競爭動態和供應商類型評估

外包生態系統中主要企業的格局和競爭動態是由全球契約製造、專業設計開發公司、臨床研究機構以及提供端到端服務的垂直整合醫療設備製造商共同塑造的。領先的服務供應商憑藉其檢驗的品管系統、法規專業知識以及在植入式醫療設備和影像設備等複雜醫療設備領域的豐富經驗而脫穎而出。策略夥伴關係關係通常包括用於監管申報的聯合藍圖、技術轉移協議以及風險共擔的商業模式。

為高階主管提供可操作且優先考慮的建議，以最佳化外包夥伴關係、管治和韌性，同時保護臨床和監管目標。

針對行業領導者的實用建議著重於使外包策略與核心臨床目標、監管義務和供應鏈韌性要求保持一致。首先，應建立一個跨部門的管治框架，涵蓋監管、品質、臨床、採購和商業等部門的相關人員，以確保外包決策能夠權衡安全性、上市時間和成本。此管治框架應統籌關鍵績效指標 (KPI)、變更管理流程和升級程序，以在整個轉移和規模化過程中維護產品完整性。

我們嚴謹透明的混合方法研究設計，結合了與關鍵相關人員的訪談、監管分析和交叉檢驗，提供了可操作的產業見解。

本研究途徑透過整合對產業從業人員、技術專家和採購經理的訪談，並輔以對監管指南、標準和同行評審文獻的系統性回顧，建構了可靠的證據基礎。主要研究著重於挖掘技術轉移和監管申報方面的營運限制因素、合作夥伴評估標準和實際經驗，從而對當前實踐和新興優先事項進行深入的定性分析。

簡潔而前瞻性的結論，整合了外包選擇對監管成功、臨床結果和營運韌性的策略影響。

總之，醫療設備外包的發展趨勢呈現日益複雜的策略態勢，合作夥伴的選擇會影響監理核准的成敗、產品上市時間和產品生命週期經濟效益。在先進技術、不斷變化的監管預期和貿易政策趨勢的交織影響下，企業需要採取謹慎的、以能力主導的外包策略，以平衡控制力和可擴展性。那些投資於管治、實質審查和供應商數位轉型的企業，更有可能將外部夥伴關係轉化為永續的臨床和商業性優勢。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：醫療設備外包市場：依服務類型分類

  • 臨床試驗
  • 設計與開發
  • 後勤
  • 製造業
    • 契約製造
    • 客製化生產
    • OEM
  • 包裝
  • 藥品法規合規性
  • 維修/保養
  • 無菌
  • 檢查和驗證

第9章：醫療設備外包市場：依器材類型分類

  • 心血管醫療設備
    • 心臟監測設備
    • 導管
    • 心臟瓣膜
    • 支架
  • 牙科設備
  • 影像設備
    • 電腦斷層掃描器
    • 磁振造影系統
    • 核醫學影像設備
    • 超音波診斷設備
    • X光設備
  • 耳鼻喉科醫療設備
  • 體外診斷醫療設備
  • 眼科醫療設備
  • 整形外科醫療設備
  • 手術器械

第10章：醫療設備外包市場：依外包模式分類

  • 共同採購
  • 完全外包
  • 內部資源

第11章：醫療設備外包市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 診斷實驗室
  • 居家醫療
  • 醫院
  • 研究機構

第12章：醫療設備外包市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：醫療設備外包市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：醫療設備外包市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國醫療設備外包市場

第16章：中國醫療設備外包市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advantech Plastics, LLC
  • Angiplast Private Limited
  • Benchmark Electronics, Inc.
  • C & J Industries, Inc.
  • Cadence, Inc.
  • Carclo PLC
  • Celestica Inc.
  • Cirtronics Corp.
  • Federal Electronics, Inc.
  • Flex Medical Solutions Ltd
  • Forefront Medical Technologies
  • Gerresheimer AG
  • HDA Technology, Inc.
  • Integer Holdings Corporation
  • Plexus Corp.
  • Poly Medicure Ltd.
  • Recipharm AB
  • Remington Medical, Inc.
  • Sanbor Medical
  • Sanmina Corporation
  • SeaskyMedical
  • Tessy Plastics Corp.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-43470FC608C2

The Medical Device Outsourcing Market was valued at USD 146.50 billion in 2025 and is projected to grow to USD 157.60 billion in 2026, with a CAGR of 9.23%, reaching USD 271.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 146.50 billion
Estimated Year [2026] USD 157.60 billion
Forecast Year [2032] USD 271.82 billion
CAGR (%) 9.23%

An essential introduction to how evolving clinical, regulatory, and supply dynamics are reshaping outsourcing strategies across the medical device lifecycle

The contemporary medical device landscape is undergoing a period of intense recalibration driven by regulatory evolution, technological convergence, and shifting provider economics. Stakeholders across the device innovation lifecycle are reevaluating which functions to retain in-house and which to externalize, seeking partners that can deliver not only cost efficiencies but also regulatory acumen, quality assurance, and innovation enablement. This pivot is justified as organizations confront compressed product development timelines, increasing complexity of combination products, and heightened scrutiny on supply chain integrity.

Against this backdrop, outsourcing choices are no longer transactional supplier relationships but strategic alliances that influence speed to market, post-market surveillance capability, and long-term product viability. Companies that articulate clear outsourcing criteria tied to clinical value, regulatory risk mitigation, and lifecycle maintenance are better positioned to capture clinical and commercial upside. Moreover, the emergence of precision diagnostics, integrated digital therapeutics, and advanced materials imposes new technical requirements on external partners, making due diligence on capability breadth and depth indispensable.

Transitioning thoughtfully requires cross-functional governance, measurable performance indicators, and an integrated supplier management approach. By framing outsourcing decisions as extensions of core competencies rather than simple cost arbitrage, organizations can create resilient operational models that support iterative innovation while preserving patient safety and regulatory compliance.

A forward-looking exploration of the convergent technological, regulatory, and commercial shifts that are redefining outsourcing partnerships and expectations

Transformative shifts are reshaping where and how device firms source critical services, and these shifts are driven by convergent forces across technology, regulation, and market access. Digitization and data analytics are enabling remote monitoring, predictive quality control, and virtualized clinical operations, which in turn influence partner selection criteria and contractual performance metrics. Concurrently, regulatory bodies are raising expectations for traceability, cybersecurity for connected devices, and post-market evidence, prompting manufacturers to favor outsourcing partners with demonstrated regulatory foresight and integrated compliance infrastructure.

Supply chain resilience has moved to the forefront of strategic planning. Organizations are actively reconfiguring supplier portfolios to mitigate single-source risks, shorten lead times, and localize critical manufacturing where feasible. This realignment favors partners that can provide end-to-end visibility, responsive capacity, and validated contingency plans. At the same time, the trend toward personalized and combination products is driving demand for flexible manufacturing platforms and specialized development services that can accommodate small-batch, high-complexity production runs.

Finally, payer and provider pressures for value-based outcomes are influencing product design and lifecycle support models. Outsourcing relationships increasingly incorporate performance-based elements tied to clinical outcomes, device uptime, and total cost of ownership. As a result, the most transformative shifts are not merely operational but contractual and strategic, redefining how risk and rewards are shared between device companies and their external partners.

An integrated analysis of how evolving tariff pressures are catalyzing geographic sourcing realignments and reshaping total cost and compliance strategies

The tariff environment in the United States has introduced added complexity into sourcing strategies, prompting organizations to reexamine supplier geographies, tariff class exposure, and landed cost modeling. Trade policy adjustments have made it prudent to revisit the total cost equation for cross-border sourcing, particularly for components and subassemblies that traverse multiple jurisdictions before final assembly. Firms are adapting by increasing supply chain transparency, renegotiating terms with strategic suppliers, and evaluating nearshoring options to reduce tariff-driven volatility.

In response to tariff-related headwinds, many organizations have accelerated investments in localized manufacturing capabilities or in regional partners that can offer tariff-advantaged operations. This nearshoring trend is often paired with supplier qualification programs that emphasize speed of qualification and dual-sourcing plans to preserve continuity while controlling cost impacts. At the same time, procurement teams are deploying more granular bill-of-materials analysis and tariff classification reviews to identify reclassification opportunities and to optimize trade compliance strategies.

Transitioning manufacturing and sourcing footprints carries its own set of operational and regulatory trade-offs, including qualification timelines and potential supply interruptions during transfer. As a result, decision-makers weigh tariff mitigation against the readiness of alternate suppliers, the regulatory implications of manufacturing transfers, and the long-term resilience benefits. These deliberations underscore the need for a holistic approach that aligns trade policy response with regulatory strategy, quality assurance, and commercial timelines.

Deep segmentation insights that link service categories, device complexities, end-user behaviors, and outsourcing models to partnership design and risk allocation

Segmentation insights reveal differentiated demand drivers across service types, device categories, end users, and outsourcing models, each demanding tailored partner capabilities and contract structures. Based on service type, the market includes Clinical Trials, Design And Development, Logistics, Manufacturing, Packaging, Regulatory Affairs, Repair And Maintenance, Sterilization, and Testing And Validation, with Manufacturing further differentiated into Contract Manufacturing, Custom Manufacturing, and Original Equipment Manufacturing. Each service node carries distinct quality, traceability, and regulatory documentation expectations, which influence partner evaluation criteria and governance models.

Based on device type, the landscape spans Cardiovascular Devices, Dental Devices, Diagnostic Imaging Devices, ENT Devices, In Vitro Diagnostic Devices, Ophthalmic Devices, Orthopedic Devices, and Surgical Instruments. Within Cardiovascular Devices, subcategories include Cardiac Monitoring Devices, Catheters, Heart Valves, and Stents, while Diagnostic Imaging Devices encompass Computed Tomography Scanner, Magnetic Resonance Imaging, Nuclear Imaging Systems, Ultrasound Systems, and X Ray Systems. These device-driven technical demands dictate the specialization required of outsourcing partners, from biocompatible materials expertise for implants to high-precision assembly for imaging systems.

Based on end user, the market is served by Ambulatory Surgical Centers, Clinics, Diagnostic Laboratories, Home Healthcare providers, Hospitals, and Research Institutes, each with unique procurement cycles, inventory dynamics, and service expectations. Based on outsourcing model, organizations choose among Co Sourced, Fully Outsourced, and Insourced approaches, reflecting different risk tolerances, strategic priorities, and control requirements. Understanding the interaction between service type, device complexity, end-user environment, and chosen outsourcing model is essential to designing contracts that deliver clinical reliability, regulatory compliance, and commercial value.

Regionally differentiated strategic considerations for outsourcing that balance regulatory pathways, cost structures, and proximity to innovation and markets

Regional dynamics significantly influence sourcing strategies, regulatory timelines, and cost structures across the Americas, Europe, Middle East & Africa, and Asia-Pacific, each presenting distinct advantages and constraints for outsourcing. In the Americas, proximity to large healthcare markets and a mature regulatory framework support nearshore manufacturing and rapid clinical collaboration, but rising labor and compliance costs incline some firms toward automation and capacity optimization.

In Europe, Middle East & Africa, regulatory harmonization across many jurisdictions, skilled manufacturing bases, and robust quality ecosystems encourage sophisticated outsourced services, particularly for device types requiring rigorous conformity assessment and post-market surveillance. The region also presents complex market access pathways that favor partners with in-region regulatory expertise. In the Asia-Pacific, scale manufacturing capabilities, growing technical service providers, and competitive cost structures make the region attractive for high-volume production and component sourcing, while ongoing investments in quality systems and regulatory maturity are narrowing historical gaps.

Cross-regional strategies increasingly combine strengths from multiple regions: design and complex development may remain close to innovation hubs, while scalable manufacturing leverages cost-competitive regions, and specialized validation or regulatory support is allocated to partners with local expertise. Navigating these regional advantages requires a deliberate approach to compliance, intellectual property protection, and supplier diversification to preserve continuity and protect product integrity.

An assessment of competitive dynamics and provider archetypes that highlights how capability depth, regulatory expertise, and digital investments drive partner selection

Key company profiles and competitive dynamics in the outsourcing ecosystem are shaped by a mix of global contract manufacturers, specialized design and development firms, clinical research organizations, and vertically integrated device companies offering end-to-end services. Leading service providers differentiate through validated quality management systems, regulatory intelligence, and demonstrated experience with complex device classes such as implantables and diagnostic imaging equipment. Strategic partnerships frequently include joint roadmaps for regulatory submissions, technology transfer protocols, and shared risk commercial models.

Smaller, highly specialized firms are carving niches around advanced materials, miniaturized electronics, and combination product regulatory navigation, and they often serve as catalysts for innovation by enabling rapid prototyping and flexible small-batch manufacturing. At the same time, integrated players that offer bundled services-from design and preclinical testing through sterilization, validation, and post-market support-appeal to OEMs seeking single-point accountability and streamlined supplier management. Competitive differentiation also emerges from investments in digital platforms for supply chain visibility, quality analytics, and remote monitoring, which reduce time to qualification and improve predictability.

Strategic alliances, mergers and acquisitions, and capability-building partnerships are common as providers expand end-to-end offerings or deepen specialization. For device companies, selecting partners thus becomes an exercise in mapping provider capabilities against product complexity, regulatory risk, and long-term support needs.

Practical and prioritized recommendations for executives to optimize outsourcing partnerships, governance, and resilience while protecting clinical and regulatory objectives

Actionable recommendations for industry leaders center on aligning outsourcing strategy with core clinical objectives, regulatory obligations, and supply chain resilience requirements. First, embed cross-functional governance that includes regulatory, quality, clinical, procurement, and commercial stakeholders to ensure outsourcing decisions reflect trade-offs across safety, time-to-market, and cost. This governance should govern key performance indicators, change control processes, and escalation pathways to preserve product integrity during transfers and scale-ups.

Second, prioritize partner due diligence that assesses not only technical capability but also regulatory track record, data integrity practices, and cyber-physical security for connected device elements. Preferred partners will demonstrate end-to-end traceability, validated computerized systems, and experience navigating regional conformity assessments. Third, adopt a mixed sourcing approach that leverages co-sourced models for strategic capabilities while fully outsourcing commoditized, high-volume manufacturing. This hybrid model preserves control over critical IP and design intent while extracting efficiencies from specialized providers.

Finally, invest in supplier digitalization to enable real-time visibility into quality metrics, inventory, and production scheduling. Coupled with scenario planning for tariff and geopolitical disruptions, these investments will support resilient operations and faster corrective actions. Leaders should view outsourcing partnerships as strategic levers that can accelerate innovation, reduce regulatory friction, and enhance patient-centric outcomes when governed and executed with rigor.

A rigorous and transparent mixed-method research design combining primary stakeholder interviews, regulatory analysis, and cross-validation to deliver actionable industry insights

The research approach integrates primary interviews with industry practitioners, technical experts, and procurement leaders, supplemented by a systematic review of regulatory guidance, standards, and peer-reviewed literature to build a robust evidence base. Primary inquiry focused on eliciting operational constraints, partner evaluation criteria, and the lived experience of technology transfers and regulatory submissions, enabling a rich qualitative understanding of current practices and emerging priorities.

Secondary analysis consolidated publicly available regulatory updates, quality system guidance, and industry white papers to triangulate primary insights and ensure alignment with contemporary compliance expectations. The methodology emphasizes transparency in source attribution, rigorous cross-validation of interview findings, and a structured framework for mapping capabilities across service types, device classes, end users, and outsourcing models. Where appropriate, scenario analysis and sensitivity review were applied to assess strategic responses to trade policy shifts and supply chain disruptions.

Quality assurance for the research process included expert peer review of thematic interpretations and a verification step with select interviewees to confirm the accuracy of presented narratives. This layered approach delivers practical insights grounded in real-world operational experience and current regulatory context.

A concise and forward-looking conclusion that synthesizes strategic implications of outsourcing choices for regulatory success, clinical outcomes, and operational resilience

In conclusion, the trajectory of medical device outsourcing is characterized by increasing strategic complexity, where partner selection influences regulatory success, time to market, and product lifecycle economics. The interplay of advanced technologies, evolving regulatory expectations, and trade policy dynamics necessitates a deliberate, capability-driven approach to outsourcing that balances control with scalability. Organizations that invest in governance, due diligence, and supplier digitalization will be better positioned to translate external partnerships into sustained clinical and commercial advantage.

Looking ahead, outsourcing will continue to evolve from discrete transactions into integrated partnerships that share accountability for clinical outcomes, quality performance, and post-market stewardship. Firms that treat outsourcing as a strategic extension of their innovation engine, rather than a cost-cutting exercise, will capture the greatest long-term value. By aligning procurement, regulatory strategy, and clinical objectives, device manufacturers can create robust ecosystems of external partners that accelerate innovation while maintaining the highest standards of patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Device Outsourcing Market, by Service Type

  • 8.1. Clinical Trials
  • 8.2. Design And Development
  • 8.3. Logistics
  • 8.4. Manufacturing
    • 8.4.1. Contract Manufacturing
    • 8.4.2. Custom Manufacturing
    • 8.4.3. Original Equipment Manufacturing
  • 8.5. Packaging
  • 8.6. Regulatory Affairs
  • 8.7. Repair And Maintenance
  • 8.8. Sterilization
  • 8.9. Testing And Validation

9. Medical Device Outsourcing Market, by Device Type

  • 9.1. Cardiovascular Devices
    • 9.1.1. Cardiac Monitoring Devices
    • 9.1.2. Catheters
    • 9.1.3. Heart Valves
    • 9.1.4. Stents
  • 9.2. Dental Devices
  • 9.3. Diagnostic Imaging Devices
    • 9.3.1. Computed Tomography Scanner
    • 9.3.2. Magnetic Resonance Imaging
    • 9.3.3. Nuclear Imaging Systems
    • 9.3.4. Ultrasound Systems
    • 9.3.5. X Ray Systems
  • 9.4. Ent Devices
  • 9.5. In Vitro Diagnostic Devices
  • 9.6. Ophthalmic Devices
  • 9.7. Orthopedic Devices
  • 9.8. Surgical Instruments

10. Medical Device Outsourcing Market, by Outsourcing Model

  • 10.1. Co Sourced
  • 10.2. Fully Outsourced
  • 10.3. Insourced

11. Medical Device Outsourcing Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Home Healthcare
  • 11.5. Hospitals
  • 11.6. Research Institutes

12. Medical Device Outsourcing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Medical Device Outsourcing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Medical Device Outsourcing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Medical Device Outsourcing Market

16. China Medical Device Outsourcing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Advantech Plastics, LLC
  • 17.6. Angiplast Private Limited
  • 17.7. Benchmark Electronics, Inc.
  • 17.8. C & J Industries, Inc.
  • 17.9. Cadence, Inc.
  • 17.10. Carclo PLC
  • 17.11. Celestica Inc.
  • 17.12. Cirtronics Corp.
  • 17.13. Federal Electronics, Inc.
  • 17.14. Flex Medical Solutions Ltd
  • 17.15. Forefront Medical Technologies
  • 17.16. Gerresheimer AG
  • 17.17. HDA Technology, Inc.
  • 17.18. Integer Holdings Corporation
  • 17.19. Plexus Corp.
  • 17.20. Poly Medicure Ltd.
  • 17.21. Recipharm AB
  • 17.22. Remington Medical, Inc.
  • 17.23. Sanbor Medical
  • 17.24. Sanmina Corporation
  • 17.25. SeaskyMedical
  • 17.26. Tessy Plastics Corp.
  • 17.27. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DESIGN AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DESIGN AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DESIGN AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CUSTOM MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CUSTOM MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CUSTOM MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REGULATORY AFFAIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REPAIR AND MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REPAIR AND MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REPAIR AND MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STERILIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STERILIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY TESTING AND VALIDATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY TESTING AND VALIDATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY TESTING AND VALIDATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIAC MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DENTAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DENTAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DENTAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COMPUTED TOMOGRAPHY SCANNER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY NUCLEAR IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY X RAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY X RAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY X RAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ENT DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ENT DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ENT DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OPHTHALMIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OPHTHALMIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY ORTHOPEDIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SURGICAL INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CO SOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CO SOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CO SOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY FULLY OUTSOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY FULLY OUTSOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY FULLY OUTSOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY INSOURCED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY INSOURCED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY INSOURCED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 204. GCC MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 224. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 232. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY MANUFACTURING, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR DEVICES, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY OUTSOURCING MODEL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL DEVICE OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)